Inhibition of the Topoisomerase II-DNA Cleavable Complex by the ortho -Quinone Derivative of the Antitumor Drug Etoposide (VP-16)

By Gantchev T.G.   Hunting D.J.  

Biochemical and Biophysical Research Communications, Vol. 237, Iss. 1, 1997-08 ,pp. : 24-27

Elsevier

Access to resources Recommend Favorite

DNA Topoisomerase II as the Cellular Target of a Novel Antitumor Agent ICRF-193, a Bisdioxopiperazine Derivative, inXenopusEgg Extract

By Sato M.   Ishida R.   Ohsumi K.   Narita T.   Andoh T.  

Biochemical and Biophysical Research Communications, Vol. 235, Iss. 3, 1997-06 ,pp. : 571-575

Elsevier

Access to resources Recommend Favorite

Inhibition of DNA Topoisomerase II in Living Cells Stimulates Illegitimate Recombination

By Umanskaya O.   Ioudinkova E.   Razin S.   Bystritskiy A.  

Doklady Biochemistry & Biophysics, Vol. 405, Iss. 1-6, 2005-11 ,pp. : 423-425

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Induction of unique structural changes in guanine-rich DNA regions by the triazoloacridone C-1305, a topoisomerase II inhibitor with antitumor activities

By Lemke Krzysztof   Wojciechowski Marcin   Laine William   Bailly Christian   Colson Pierre   Baginski Maciej   Larsen Annette K.   Skladanowski Andrzej  

Nucleic Acids Research, Vol. 33, Iss. 18, 2005-01 ,pp. : 6034-6047

Oxford University Press

Access to resources Recommend Favorite

Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage

By Barker Catherine R.   McNamara Anne V.   Rackstraw Stephen A.   Nelson David E.   White Mike R.   Watson Alastair J. M.   Jenkins John R.  

Nucleic Acids Research, Vol. 34, Iss. 4, 2006-01 ,pp. : 1148-1157

Oxford University Press

Access to resources Recommend Favorite